Jupiter Neurosciences Inc share price logo

Jupiter Neurosciences Inc Share Price

NASDAQ: JUNS

Small Cap

$1.41

+0.03

(+1.81%)

as on

Jupiter Neurosciences Inc Stock Performance

as on November 1, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.37
    $1.46
    downward going graph

    2.84%

    Downside

    3.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.51
    $19.51
    downward going graph

    63.83%

    Downside

    1283.69%

    Upside

    downward going graph

Jupiter Neurosciences Inc share price movements today

Previous Close
$1.38
Open
$1.41
Volume
630.3K
Day's Low - High
$1.37 - $1.46
52 Week Low - High
$0.51 - $19.51

Jupiter Neurosciences Inc Historical Returns

1 Month Return
-15.88 %
3 Month Return
+ 5.15 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Jupiter Neurosciences Inc Stock Fundamentals & Key Indicators

Check Jupiter Neurosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$48.1M

EPS (TTM)

-0.26

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

0.00%

Jupiter Neurosciences Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Jupiter Neurosciences Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Jupiter Neurosciences Inc image
Jupiter Neurosciences Inc
NA$48.1MNANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$40.4B475.59%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$59.4B270.85%-505.15-12.96%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$107.7B104.25%29.8431.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$68.7B19.91%15.6732.13%

Jupiter Neurosciences Inc Stock’s Investor Sentiment and Interest

Search interest for Jupiter Neurosciences Inc Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

Jupiter Neurosciences Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
Operating Income
-1
0
0
0
0
-1
-1
-2
EBITDA
-1
0
0
0
0
-1
-1
-2
Interest Expense
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-1
0
0
0
0
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-1
0
0
0
0
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Jupiter Neurosciences Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
0
0
-
-
Gross Profit
1
0
0
-
-
Operating Income
-1
-3
-3
-3
-3
EBITDA
-1
-4
-4
-4
-2
Interest Expense
0
0
0
0
0
Depreciation
-
-
-
-
-
Income Before Tax
-1
-4
-4
-4
-2
Income Tax Expense
-
0
-
-
-
Net Income
-1
-4
-4
-4
-2
Net Profit Margin
-146.92%
-686.39%
-2125.15%
0.00%
0.00%

Jupiter Neurosciences Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
0
-1
0
0
0
0
-1
-1
-2
Operating Cash Flow
0
0
0
0
0
0
-3
-1
0
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
0
0
0
7
-
-
Change in Cash
0
0
0
0
0
0
3
-1
0

Jupiter Neurosciences Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-1
-4
-4
-4
-2
Operating Cash Flow
0
-1
-1
0
-3
Investing Cash Flow
-
-
-
-
-
Financing Cash Flow
0
1
0
0
7
Change in Cash
0
0
0
0
3

Insights on Jupiter Neurosciences Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, JUNS stock has moved down by -18.8%

About Jupiter Neurosciences Inc

Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.
OrganisationJupiter Neurosciences Inc
Headquarters1001 North US Highway 1, Jupiter, FL, United States, 33477
CEOMr. Christer Rosen
E-voting on sharesClick here to vote

Key Management of Jupiter Neurosciences Inc

Name

Title

Mr. Alexander Rosen

Co-Founder & Chief Administrative Officer

Mr. Saleem Elmasri CPA

CFO & Secretary

Dr. Claes Wahlestedt M.D., Ph.D.

Co-Founder, Co-Chairman of Scientific Advisory Board & Consulting Chief Medical Officer

Dr. Shaun P. Brothers Ph.D.

Co-Founder Member of Scientific Advisory Board & Consulting Vice President of Science Research

Mr. Christer Rosen

Co-Founder, CEO & Chairman of the Board

Ms. Alison D. Silva MA, MS

President, Chief Business Officer & Director

Dr. Marshall Hayward Ph.D.

Co-Founder, Chief Scientific Officer & Director

FAQs

What is Jupiter Neurosciences Inc share price today?

Jupiter Neurosciences Inc share price today is $1.41 as on at the close of the market. Jupiter Neurosciences Inc share today touched a day high of $1.46 and a low of $1.37.

What is the 52 week high and 52 week low for Jupiter Neurosciences Inc share?

Jupiter Neurosciences Inc share touched a 52 week high of $19.51 on and a 52 week low of $0.51 on . Jupiter Neurosciences Inc stock price today i.e. is closed at $1.41,which is 92.77% down from its 52 week high and 176.47% up from its 52 week low.

What is Jupiter Neurosciences Inc's market capitalisation today?

Jupiter Neurosciences Inc market capitalisation is $0.00T as on .

How to invest in Jupiter Neurosciences Inc Stock (JUNS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Jupiter Neurosciences Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Jupiter Neurosciences Inc Shares that will get you 1.0638 shares as per Jupiter Neurosciences Inc share price of $1.41 per share as on November 1, 2025 at 1:29 am IST.

What is the minimum amount required to buy Jupiter Neurosciences Inc Stock (JUNS) from India?

Indian investors can start investing in Jupiter Neurosciences Inc (JUNS) shares with as little as ₹88.719 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.19 in Jupiter Neurosciences Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Jupiter Neurosciences Inc share’s latest price of $1.41 as on November 1, 2025 at 1:29 am IST, you will get 7.0922 shares of Jupiter Neurosciences Inc. Learn more about fractional shares .